iSpecimen Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for iSpecimen.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for iSpecimen.

Recommendation Trends

Rating	Jun '22	Jul '22	Aug '22
Strong Buy	2	2	2
Buy	0	0	0
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Constantine Davides EF Hutton	EF Hutton	Strong Buy Maintains $110 → $85	Strong Buy	Maintains	$110 → $85	+1,764.04%	Sep 23, 2022
Matt Hewitt Craig-Hallum	Craig-Hallum	Strong Buy Initiates $400	Strong Buy	Initiates	$400	+8,671.93%	Jan 4, 2022
Constantine Davides EF Hutton	EF Hutton	Strong Buy Maintains $200 → $240	Strong Buy	Maintains	$200 → $240	+5,163.16%	Nov 22, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 1.93M

Revenue Next Year

n/a

EPS This Year

n/a

from -2.28

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	11.14M	10.40M	9.93M	9.29M	1.93M
Revenue Growth	36.06%	-6.58%	-4.56%	-6.42%	-79.24%
EPS	-41.81	-23.20	-24.55	-17.58	-2.28
EPS Growth	-	-	-	-	-
Forward PE	-	-	-	-	-
No. Analysts	-	-	-	-	-

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.